Posts in: heltzen

Pix11 "Top Leaders" featuring EXOZ CEO, Heltzen
heltzeninvestorpress clippingsvideoNCT
Pix11 News: Reinventing How Medicine Is MadeOctober 8, 2026
Heltzen on Grow Everything podcast, episode #201
heltzennutraceuticalspress clippingsvideoNCT
Grow Everything podcast: Out of Cell Experience - Heltzen Drives Pure ChemistryOctober 2, 2026
Q&A: Tyler Korman, Michael Heltzen, Damien Perriman
heltzeninvestorvideoperrimankorman
Transcript: Q2 2026 investor update from EXOZAugust 21, 2026
Q2 2026 investor update
heltzenpress releaseinvestor
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET todayAugust 20, 2026
EXOZ and LBNL awarded Genesis Mission grant from DOE
heltzenpress releasescience
eXoZymes selected for DoE’s Genesis Mission to advance AI-powered digital twins for cell-free biomanufacturingJuly 23, 2026
EXOZ gets $2 Million NIH Grant to Advance Cannabinoids for Drug Discovery
heltzenpress releaseinvestormedicinesciencecannabinoidskorman
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug DiscoveryJune 24, 2026
WTR Healthcare Happenings
heltzennutraceuticalspress clippingspodcastNCT
WTR podcast: Unlocking Hard-to-Scale Molecules with AI-Driven, Cell-Free BiomanufacturingMay 6, 2026
Podcast: CEO Heltzen @ Executive Insights for Life Sciences Innovators
heltzenpress clippingsvideopodcast
Podcast: CEO Heltzen @ Executive Insights for Life Sciences InnovatorsApril 20, 2026
Biotech Bulls & Breakthroughs podcast: The Future of Biomanufacturing with Michael Heltzen
heltzenpress clippingsvideopodcast
Biotech Bulls & Breakthroughs podcast: The Future of Biomanufacturing with Michael HeltzenApril 13, 2026
Nasdaq's 'Amplify Spotlight'
heltzeninvestorpress clippingsvideo
Nasdaq: Michael B. Spector interviews CEO HeltzenFebruary 5, 2026
Previous page
Page 1 of 3
Next page